InsidersTradesSigma
Follow the 博晖创新 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 博晖创新 has logged 2 reports. Market capitalisation: €3.8bn. The latest transaction was disclosed on 5 January 2022 (Sale). Among the most active insiders: 牛树荟. The full history is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€602,578
2 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,813 of 28,855 companies
25.9
score / 100
Value22
Quality30
FCF yld-7.7%
Earn yld-2.4%
EV/EBITDA·
ROE-8.0%
Gross mgn40%
Net mgn-11%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 January 2022
About 博晖创新
博晖创新 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It specializes in developing innovative solutions for the medical field.